Disc Medicine (IRON) Other Non-Current Assets (2020 - 2026)
Disc Medicine's (IRON) quarterly Other Non-Current Assets came in at $721000.0 in Q1 2026, down 14.06% year-on-year from $839000.0 in Q1 2025, and down 0.69% on a QoQ basis from $726000.0 in Q4 2025.
Disc Medicine (IRON) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Other Non-Current Assets data on file, last reported at $721000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 14.06% year-over-year to $721000.0 in Q1 2026; TTM through Mar 2026 was $721000.0, a 14.06% decrease from a year earlier, with the FY2025 full-year figure at $726000.0, down 13.37% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $721000.0, down from $726000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for IRON reached as high as $1.4 million in Q3 2022 and fell as low as $116000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $470411.8 across 5 years, with a median of $236000.0 in 2024.
- Across the five-year window, Other Non-Current Assets surged 355.67% in 2022 and tumbled 91.51% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $116000.0 in 2022, then surged by 101.72% to $234000.0 in 2023, then soared by 258.12% to $838000.0 in 2024, then retreated by 13.37% to $726000.0 in 2025, then fell by 0.69% to $721000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $721000.0 in Q1 2026, $726000.0 in Q4 2025, and $840000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - | 721,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 721,000.00 |
| Dec 31, 2025 | 726,000.00 |
| Sep 30, 2025 | 840,000.00 |
| Jun 30, 2025 | 840,000.00 |
| Mar 31, 2025 | 839,000.00 |
| Dec 31, 2024 | 838,000.00 |
| Sep 30, 2024 | 236,000.00 |
| Jun 30, 2024 | 236,000.00 |
| Mar 31, 2024 | 235,000.00 |
| Dec 31, 2023 | 234,000.00 |
| Sep 30, 2023 | 116,000.00 |
| Jun 30, 2023 | 116,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | 217,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 323,000.00 |